Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1844 News Items found In the Clinic The Evolution of a Lifesaving Drug: A Scientist Reflects Thursday, March 12, 2015 Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer. In the Lab Can Stem Cells Be Taught to Repair a Radiation-Damaged Brain? Friday, February 6, 2015 In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation. Q&A Setting Cancer Cells on the Right Path: A New Leukemia Drug Shows Growing Promise Friday, January 30, 2015 An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study. In the Clinic Report Highlights Advances Made at MSK That Are Changing Patients’ Lives Wednesday, January 28, 2015 An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research. In the Lab Seeing the Light: How Engineered Nerve Cells Might Curb Parkinson’s Disease Thursday, January 22, 2015 A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells. In the Lab Investigators Use Stem Cells to Study Rare Pediatric Brain Tumors Monday, December 1, 2014 Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture. Finding Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs Monday, November 17, 2014 A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors. In the Lab Beyond the Usual Suspects: Study of Noncoding DNA Reveals New Mutations Linked to Cancer Thursday, November 13, 2014 In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation. In the Lab Disorderly DNA: Researchers Simulate a Common Cause of Lung Cancer Thursday, November 6, 2014 MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement. Event A Sneak Preview of Our Annual “Major Trends” Seminar Live Webcast Monday, November 3, 2014 Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment